Explore the latest developments in the biomarker field through the 8th Annual Biomarker & Precision Medicine US Congress, which brings together experts from global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions all focussed on emerging tools and strategies within translational science, diagnostics and biomarker development.

Enable effective biomarker identification and characterization across multiple disease areas, including neuroscience, oncology & rare disease, to accelerate novel drug candidates to commercially successful products.

Integrate multi-omic technologies into your workflows to drive the development of precision medicines, with discussion of spatial technologies, single cell analysis and AI-driven imaging.

Gain novel insights into next-generation diagnostic tools in order to improve clinical outcomes. Further talks look at the implementation of companion diagnostics in drug development to enable therapeutic success.

Event link here.